Riskpilot← Back to searchSign inGet full accessVita Laboratoriot Oy
OYActiveY-tunnus 0973282-2Laivakatu 5-FDiagnostic imaging services and medical laboratory activities · NACE 8691Est. 199496 employees
Revenue 2024
EUR 16,8M
-36% vs 2023
EBITDA margin
11.1%
-70% vs 2023
Equity ratio
78.7%
Financial strength
Net profit 2024
EUR 268K
0% vs 2023
| Revenue | EUR 16,8M | -36% |
| EBITDA | EUR 1,9M | -70% |
| Net profit | EUR 268K | +0% |
| Total assets | EUR 16,9M | -9% |
| Equity | EUR 13,3M | -8% |
| Employees | 96 | — |
Legal name
Vita Laboratoriot Oy
Y-tunnus number
0973282-2
Legal form
Osakeyhtiö
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
10. elokuuta 1994
Share capital
EUR 117 732
Employees
96 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä sekä hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on keskuslaboratoriopalveluiden, muiden tutkimusten sekä muiden terveydenhuoltoalan palveluiden tuottaminen. Lisäksi yhtiön toimialaan kuuluu edellä mainittuihin toimintoihin liittyvien tavaroiden kauppa. Lisäksi yhtiö voi toimintaansa varten omistaa ja hallita kiinteää omaisuutta, osakkeita ja muita arvopapereita.
Address
Laivakatu 5-F
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 866 | 30 790 | 26 208 | 26 208 | 16 849 |
| Staff expenses | −4 364 | −5 802 | −5 859 | −5 253 | −5 337 |
| EBITDA | 5 337 | 10 236 | 6 112 | 6 172 | 1 875 |
| Depreciation & amort. | −1 272 | −633 | −1 016 | −1 076 | −1 437 |
| EBIT | 4 065 | 9 603 | 5 096 | 5 096 | 438 |
| Net financials | −4 | −9 | −5 | −4 656 | −713 |
| Profit before tax | 4 062 | 8 786 | 4 551 | 336 | −29 |
| Tax | 470 | 1 758 | 911 | 68 | −10 |
| Net profit | 3 591 | 7 028 | 3 640 | 268 | 268 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 11 748 | 17 641 | 20 121 | 18 609 | 16 949 |
| Equity | 6 388 | 13 552 | 16 594 | 14 544 | 13 345 |
| Long-term debt | 680 | 814 | 804 | 0 | 0 |
| Short-term debt | 4 680 | 3 274 | 2 724 | 2 614 | 2 400 |
| Total debt | 5 360 | 4 088 | 3 527 | 2 614 | 2 400 |
EBITDA margin
11.1%
This company
15.8%
Market median
-30% vs market
20202024
Equity ratio
78.7%
This company
38.2%
Market median
+106% vs market
20202024
Return on equity
2.0%
This company
18.4%
Market median
-89% vs market
20202024
Net profit margin
1.6%
This company
8.1%
Market median
-80% vs market
20202024
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20202024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HR Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (2) | ||
PM Audit | Audit | 2022 – 2023 |
AJ | Audit | 2013 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (8) | ||
| Chairperson | 2024 | |
| Board of Directors | 2025 | |
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Board of Directors | 2024 | |
| Board of Directors | 2021 | |
| Board of Directors | 2025 | |
| Board of Directors | 2018 | |
| Former (2) | ||
| Board of Directors | 2018 – 2020 | |
| Board of Directors | 2018 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vita Laboratoriot Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Paula Maria Roima | Audit | 0 companies |
| Antti Johannes Saarinen | Audit | 0 companies |
| Heikki Risto Hurme | Chief Executive Officer | 0 companies |
| Jukka Matti Hurme | Chairperson | 0 companies |
| Helmut Schönwerth | Board of Directors | 0 companies |
| Harri Ilari Hurme | Board of Directors | 0 companies |
| Jan Detlef Kramer | Board of Directors | 0 companies |
| Thomas Wolff | Board of Directors | 0 companies |
| Olaf Elsässer | Board of Directors | 0 companies |
| Tobias Siegfried Kramer | Board of Directors | 0 companies |
| Heiner Volker Dr Dallmeier | Board of Directors | 0 companies |
| Kirsi-Marja Aulikki Hurme | Board of Directors | 0 companies |
| Hannes Joel Aleksi Hurme | Board of Directors | 0 companies |